Nivolumab in MGMT methylated GBM episode artwork

EPISODE · Jan 27, 2023 · 20 MIN

Nivolumab in MGMT methylated GBM

from Neuro-Oncology: The Podcast · host Dr. Jasmin Jo, Dr. Michael Lim, Dr. Iyad Alnahhas

Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.

NOW PLAYING

Nivolumab in MGMT methylated GBM

0:00 20:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 20 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on January 27, 2023.

What is this episode about?

Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!